AbbVie Secures EU Approval for Expanded VENCLYXTO Use in First-Line CLL
NORTH CHICAGO, Ill., May 29, 2026 AbbVie announced that the European Commission (EC) has approved an expanded label for...
European Commission
Advertisement
Agios Secures EU Approval for PYRUKYND in Thalassemia
Cambridge, Massachusetts, USA, May 22, 2026 Agios Pharmaceuticals has announced that the European Commission (EC) has granted marketing authorization...
Pharming Wins EU Approval for Joenja in Rare Disease
Leiden, Netherlands, May 22, 2026 Pharming Group N.V. has announced that the European Commission (EC) has granted Marketing Authorization...
Rhythm Pharmaceuticals Secures EU Approval for IMCIVREE
BOSTON, MA, May 1, 2026 Rhythm Pharmaceuticals, Inc. announced that the European Commission has granted marketing authorization for IMCIVREE®...
EU Clears ANKTIVA–BCG for Bladder Cancer Therapy
Conditional Approval Expands Access to 33 Countries February 18, 2026 | Culver City, California ImmunityBio announced that the European...
Advertisements
Resverlogix Appoints Bradley Glass to Strengthen Board Governance
Calgary, Alberta — November 18, 2025 — Resverlogix Corp. (TSX: RVX), a late-stage biotechnology firm specializing in epigenetic therapies,...
WINREVAIR Achieves Phase 2 Success in CpcPH Due to HFpEF
RAHWAY, N.J., Nov. 18, 2025 — Merck (NYSE: MRK) announced positive topline results from the Phase 2 CADENCE study,...
DAWNZERA Wins CHMP Backing for Preventing Hereditary Angioedema Attacks
Carlsbad, California, 14 November 2025 – Ionis Pharmaceuticals, Inc. and Otsuka Pharmaceutical Co., Ltd. announced that the Committee for...
Advertisement
